Cargando…

Can We Efficiently Target HDAC in Cancer?

Detalles Bibliográficos
Autores principales:	Kiesslich, Tobias, Neureiter, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406325/ https://www.ncbi.nlm.nih.gov/pubmed/36011050 http://dx.doi.org/10.3390/cancers14164058

Ejemplares similares

HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer
por: Mayr, Christian, et al.
Publicado: (2021)

GERD—Barrett—Adenocarcinoma: Do We Have Suitable Prognostic and Predictive Molecular Markers?
por: Illig, Romana, et al.
Publicado: (2013)

Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets
por: Neureiter, Daniel, et al.
Publicado: (2019)

NRF2: The key to tumor- and patient-dependent chemosensitivity in biliary tract cancer?
por: Kiesslich, Tobias, et al.
Publicado: (2019)

HDAC-Linked “Proliferative” miRNA Expression Pattern in Pancreatic Neuroendocrine Tumors
por: Klieser, Eckhard, et al.
Publicado: (2018)

Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential Biomarkers
por: Mayr, Christian, et al.
Publicado: (2016)

Pharmacological Inhibition of Class IIA HDACs by LMK-235 in Pancreatic Neuroendocrine Tumor Cells
por: Wanek, Julia, et al.
Publicado: (2018)

Can we improve operating room efficiency?
por: Divatia, JV, et al.
Publicado: (2015)

Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation
por: Bekric, Dino, et al.
Publicado: (2022)

Biliary tract cancer stem cells - translational options and challenges
por: Mayr, Christian, et al.
Publicado: (2017)

Editorial: Novel therapeutic approaches for biliary tract cancer and hepatocellular carcinoma
por: Bekric, Dino, et al.
Publicado: (2023)

Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future
por: Ocker, Matthias, et al.
Publicado: (2021)

The Shorter, the Better: Can We Improve Efficiency of Idiopathic Pulmonary Fibrosis Trials?
por: Sgalla, Giacomo, et al.
Publicado: (2022)

Pain management following laparoscopy: Can we do better?
por: Tobias, Joseph D.
Publicado: (2013)

The Cancer Stem Cell Inhibitor Napabucasin (BBI608) Shows General Cytotoxicity in Biliary Tract Cancer Cells and Reduces Cancer Stem Cell Characteristics
por: Beyreis, Marlena, et al.
Publicado: (2019)

Myelodysplastic Syndrome and Histone Deacetylase Inhibitors: “To Be or Not to Be Acetylated”?
por: Stintzing, Sebastian, et al.
Publicado: (2011)

Feasibility of Kahoot! as a Real-Time Assessment Tool in (Histo-)pathology Classroom Teaching
por: Neureiter, Daniel, et al.
Publicado: (2020)

Pancreatic cancer in young adults: changes, challenges, and solutions
por: Primavesi, Florian, et al.
Publicado: (2019)

We Know the Prognosis but can We Change It?
por: Bandopadhyay, Susruta
Publicado: (2021)

Long Non-Coding RNAs in Biliary Tract Cancer—An Up-to-Date Review
por: Bekric, Dino, et al.
Publicado: (2020)

We Can Dance If We Want To (with Safety Measures)
por: Carson, Susan
Publicado: (2022)

The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells
por: Mayr, Christian, et al.
Publicado: (2015)

Cancer in southeast Asia: can we do better?
por: The Lancet Regional Health – Southeast Asia
Publicado: (2023)

How can we reach the target of glucose control in type 1 diabetes?
por: Bloomgarden, Zachary
Publicado: (2023)

Data we can trust
por: Jackson, Sarah, et al.
Publicado: (2022)

Changes we can believe in
por: Siegel, Vivian
Publicado: (2011)

Can we more efficiently save patients with vitamin K-dependent coagulopathy caused by superwarfarin intoxication?
por: Park, Jinny
Publicado: (2014)

Low VDAC1 Expression Is Associated with an Aggressive Phenotype and Reduced Overall Patient Survival in Cholangiocellular Carcinoma
por: Feichtinger, René Günther, et al.
Publicado: (2019)

Systematic Review on Optical Diagnosis of Early Gastrointestinal Neoplasia
por: Wagner, Andrej, et al.
Publicado: (2021)

How We Will, Not Whether We Can: Improving Health and Healthcare
por: Zelmer, Jennifer
Publicado: (2017)

Facing the COVID-19 emergency: we can and we do
por: Giovagnoni, Andrea
Publicado: (2020)

Ouabain at nanomolar concentrations is cytotoxic for biliary tract cancer cells
por: Mayr, Christian, et al.
Publicado: (2023)

MicroRNAs Associated with the Efficacy of Photodynamic Therapy in Biliary Tract Cancer Cell Lines
por: Wagner, Andrej, et al.
Publicado: (2014)

Class IIa HDACs in myelination
por: Velasco-Aviles, Sergio, et al.
Publicado: (2018)

Can We Do More for ISIM?
por: Asscher, A. W., et al.
Publicado: (1979)

Should we, can we, halt the rise in prescribing for pain and distress?
por: Byng, Richard
Publicado: (2020)

We can do much better than what we did
por: Lee, Sang-Hak
Publicado: (2020)

We May Develop Medications Effective Against COVID-19, but Can We Distribute Them Equitably?
por: Kersten, Daniel J., et al.
Publicado: (2020)

Crossing Surgical Borders: Where are We, Where are We Going and Can We Find the Way?
por: Khunger, Niti
Publicado: (2016)

The Crosstalk of miRNA and Oxidative Stress in the Liver: From Physiology to Pathology and Clinical Implications
por: Klieser, Eckhard, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_39js8fu2qlvpcqjctunctoo7th